ZEUS System vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Both tools offer AI-powered, cloud-based cardiac monitoring with FDA clearance and HIPAA compliance. ZEUS System focuses on continuous ECG monitoring from wearable biosensors for arrhythmia detection, particularly AFib, and integrates with iRhythm's Zio monitors. IM007, on the other hand, specializes in aggregating and analyzing data from various cardiac implantable electronic devices (CIEDs) to streamline remote monitoring workflows and reduce false alerts, also offering predictive AI for heart failure hospitalization risk.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The ZEUS System is designed to analyze ECG data from wearable biosensors, specifically integrating with Zio Watch and Zio monitors for continuous cardiac monitoring. In contrast, IM007 aggregates data from various cardiac implantable electronic devices (CIEDs) across manufacturers like Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
The ZEUS System primarily uses AI for the detection and characterization of arrhythmias, such as Atrial Fibrillation, from continuous ECG data. IM007 offers AI-driven alert management to reduce false positives from CIEDs, an FDA-cleared AI for Insertable Cardiac Monitor (ICM) ECG data analysis (ILR ECG Analyzer), and a predictive AI (SignalHF) for heart failure hospitalization risk.
The ZEUS System aids physicians by generating preliminary reports from the continuous ECG monitoring data. IM007 provides smart workflow automation features for billing, reporting, and scheduling, along with patient connectivity management, including automated SMS for disconnected patients.
The ZEUS System is indicated for patients 18 years or older who may be asymptomatic or experience transient symptoms like palpitations, requiring long-term continuous ECG monitoring for arrhythmia detection. IM007 is tailored for patients with cardiac implantable electronic devices, focusing on comprehensive remote management and heart failure risk assessment.
The ZEUS System integrates ECG data specifically from iRhythm's Zio Watch and Zio monitors. IM007 offers unified data aggregation from a wide range of cardiac implantable electronic devices across multiple manufacturers, including Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
More Comparisons
Backers
Who funded each tool's parent company.